Clarithromycin
Sold as Klacid p125, Klacid I.V., Clacee, Klacid p250, Klacid xl, Klarithran, Simayla clarithromycin, Clarihexal, Clarithromycin unicorn, Klaribin, Clacee p125, Clacee p250, Claren p125, Claren p250, Claren, Auro-clarithromycin, Claride, Clarihexal xl, Clarithromycin unicorn xl, Klarynoxa, Klarolide xl, Clarithromycin ascendis xl, Austell clarithromycin I.V., Klaristell iv, Clarithromycin unimed, Claribax, Claride xl, Clarithromycin camox, Klaristell, Claricule, Clarithromycin austell, Mylan clarithromycin, Klaryvid, Klarizon, Clarihexal125 p, Clarihexal p, Ran-clarithromycin mr, Klarithran mr
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 17
- Registrations
- 56
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Abbott Laboratories S.A. (Pty) LtdCertificate held by Abbott | Klacid p125, Klacid I.V., Clacee, Klacid p250, Klacid xl, Clacee p125, Clacee p250 | 250, 500 mg, 500mg | 280035, 280264, 290163, 290190, 310379, 410081, 410082, X0229 | S4 | PIPIL |
| MSQ Pharma (Pty) Ltd | Klarithran | 250 | 370436 | S4 | None |
| Ranbaxy (SA) (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd2 of 7 cancelled | Klarithran, Klaribin, Ran-clarithromycin mr, Klarithran mr | 125 mg/5 ml, 250 mg/5 ml, 500 mg | 370437, 380163, 380174, 380175, 380176, A390618, A390619 | S4 | PIPIL |
| Trinity Pharma (Pty) Ltd | Simayla clarithromycin, Mylan clarithromycin | 250 mg, 500 mg | 370438, 370439, A380630, A380631 | S4 | None |
| Sandoz South Africa (Pty) LtdCertificate held by Sandoz SA (Pty) Ltd | Clarihexal, Clarithromycin unicorn, Clarihexal xl, Clarithromycin unicorn xl, Clarihexal125 p, Clarihexal p | 250, 500 mg | 380006, 380008, 430859, 430860, A390292, A390293 | S4 | PIPIL |
| Specpharm (Pty) Ltd | Claren p125, Claren p250 | Not stated | 410249, 410250 | S4 | None |
| Cospharm Investments (Pty) Ltd | Claren | 250, 500 | 410405, A400555 | S4 | None |
| Aurogen South Africa (Pty) Ltd | Klaribin, Auro-clarithromycin | 250 mg, 500 mg | 420852, 420853, 420854, 420861 | S4 | None |
| Pharmacare limited û woodmeadCertificate held by Aspen pharmacare | Claride, Claride xl | injection, 250, 500 mg | 430492, 530648, A380665, A380666 | S4 | PIPIL |
| Teva Pharmaceuticals (Pty) LtdCancelled | Klarynoxa | 500 | 450026 | S4 | None |
| Ascendis Pharma (Pty) LtdCancelled | Klarolide xl, Clarithromycin ascendis xl | 500 | 470839, 470840.839 | S4 | None |
| Camox Pharmaceuticals (Pty) Ltd | Austell clarithromycin I.V., Klaristell iv | 500 mg | 490679, 490680 | S4 | PIPIL |
| Unimed Healthcare (Pty) Ltd | Clarithromycin unimed, Klaryvid | 250, 500 mg | 500585, A380720, A380721 | S4 | PIPIL |
| Lamar International (Pty) Ltd | Claribax | 500 mg | 510193 | S4 | PIPIL |
| Austell Pharmaceuticals (Pty) Ltd | Clarithromycin camox, Klaristell, Clarithromycin austell | 250 MG, 500 MG | 540381, 540382, 540383.381, 540384.382, A380475, A380476 | S4 | None |
| Ruby Pharmaceuticals (Pty) Ltd | Claricule | 500 mg | 550075 | S4 | PIPIL |
| Biotech Laboratories (Pty) Ltd | Klarizon | 250 or 500 mg | A380724, A380725 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Klacid p125 EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 125,0 mg | Not listed | 28003528/20.1.1/0035 | Registered | S4 | None |
| Klacid I.V.* EACH VIAL CONTAINS CLARITHROMYCIN 500 mg | Not listed | 28026428/20.1.1/0264 | Registered | S4 | None |
| Clacee 500 MG EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 mg | 29016329/20.1.1/0163 | Registered | S4 | None |
| Klacid p250* EACH 5 ml SUSPENSION CONTAINS CLARITHROMYCIN 250 mg | Not listed | 29019029/20.1.1/0190 | Registered | S4 | None |
| Klacid xl EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500mgTablet | 31037931/20.1.1/0379Approved 1 December 2006 | Registered | S4 | PIPIL |
| Klarithran 250 tablets EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250Tablets | 37043637/20.1.1/0436 | Registered | S4 | None |
| Klarithran 500 tablets EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500Tablets | 37043737/20.1.1/0437 | Registered | S4 | None |
| Simayla clarithromycin 250 EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250 | 37043837/20.1.1/0438 | Registered | S4 | None |
| Simayla clarithromycin 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 | 37043937/20.1.1/0439 | Registered | S4 | None |
| Clarihexal 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 mgFilm-coated tablets | 38000638/20.1.1/0006Approved 5 August 2021 | Registered | S4 | PIPIL |
| Clarithromycin unicorn 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 Mg | 500 | 38000838/20.1.1/0008 | Registered | S4 | None |
| Klaribin 250 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 250,0 mg | 250 mg/5 ml | 38016338/20.1.1/0163 | Cancelled | S4 | None |
| Klarithran suspension 125 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 125,0 mg | 125 mg/5 mlSuspension | 38017438/20.1.1/0174 | Registered | S4 | None |
| Klarithran suspension 250 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 250,0 mg | 250 mg/5 mlSuspension | 38017538/20.1.1/0175 | Registered | S4 | None |
| Klaribin 125 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 125,0 mg | 125 mg/5 ml | 38017638/20.1.1/0176 | Cancelled | S4 | None |
| Clacee p125 EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 125,0 mg | Not listed | 41008141/20.1.1/0081 | Registered | S4 | None |
| Clacee p250 EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 250,0 mg | Not listed | 41008241/20.1.1/0082 | Registered | S4 | None |
| Claren p125 EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 125,0 mg | Not listed | 41024941/20.1.1/0249 | Registered | S4 | None |
| Claren p250 EACH 5,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 250,0 mg | Not listed | 41025041/20.1.1/0250 | Registered | S4 | None |
| Claren 250 EACH TABLET CONTAINS :CLARITHROMYCIN 250,0 mg | 250 | 41040541/20.1.1/0405 | Registered | S4 | None |
| Klaribin tablets 250 MG EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250 mgTablets | 42085242/20.1.1/0852 | Registered | S4 | None |
| Klaribin tablets 500 MG EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 mgTablets | 42085342/20.1.1/0853 | Registered | S4 | None |
| Auro-clarithromycin tablets 250 MG EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250 mgTablets | 42085442/20.1.1/0854 | Registered | S4 | None |
| Auro-clarithromycin tablets 500 MG EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 mgTablets | 42086142/20.1.1/0861 | Registered | S4 | None |
| Claride injection EACH VIAL CONTAINS CLARITHROMYCIN 500,0 mg | Injection | 43049243/20.1.1/0492 | Registered | S4 | None |
| Clarihexal 500 xl EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 | 43085943/20.1.1/0859 | Registered | S4 | None |
| Clarithromycin unicorn 500 xl EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 | 43086043/20.1.1/0860 | Registered | S4 | None |
| Klarynoxa 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 | 45002645/20.1.1/0026 | Cancelled | S4 | None |
| Klarolide xl 500 EACH TABLET CONTAINS: CLARITHROMYCIN CITRATE EQUIVALENT TO CLARITHROMYCIN 500,0 mg | 500 | 47083947/20.1.1/0839 | Cancelled | S4 | None |
| Clarithromycin ascendis xl 500 EACH TABLET CONTAINS: CLARITHROMYCIN CITRATE EQUIVALENT TO CLARITHROMYCIN 500,0 mg | 500 | 470840.83947/20.1.1/0840.839 | Cancelled | S4 | None |
| Austell clarithromycin I.V. EACH VIAL CONTAINS :CLARITHROMYCIN 500,0 mg | 500 mgPowder for solution for injection | 49067949/20.1.1/0679Approved 29 June 2023 | Registered | S4 | PIPIL |
| Klaristell iv EACH VIAL CONTAINS :CLARITHROMYCIN 500,0 mg | 500 mgPowder for solution for injection | 49068049/20.1.1/0680Approved 29 June 2023 | Registered | S4 | PIPIL |
| Clarithromycin unimed 500 | 500 mgFilm-coated tablets | 50058550/20.1.1/0585Approved 14 May 2024 | Registered | S4 | PIPIL |
| Claribax Each Tablets Contains: Clarithromycin 500,0 mg | 500 mgFilm-coated tablets | 51019351/20.1.1/0193Approved 10 January 2025 | Registered | S4 | PIPIL |
| Claride xl EACH TABLET CONTAINS CLARITHROMYCIN CITRATE 500,0 mg | 500 mgModified release tablets | 53064853/20.1.1/0648Approved 8 October 2024 | Registered | S4 | PIPIL |
| Clarithromycin 250 camox EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250 | 54038154/20.1.1/0381 | Registered | S4 | None |
| Clarithromycin 500 camox EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 | 54038254/20.1.1/0382 | Registered | S4 | None |
| Klaristell 250 EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250 | 540383.38154/20.1.1/0383.381 | Registered | S4 | None |
| Klaristell 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 | 540384.38254/20.1.1/0384.382 | Registered | S4 | None |
| Claricule EACH VIAL CONTAINS CLARITHROMYCIN 500,0 mg | 500 mgPowder for solution for infusion | 55007555/20.1.1/0075Approved 15 November 2023 | Registered | S4 | PIPIL |
| Clarithromycin 250 MG austell EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250 MG | A380475A38/20.1.1/0475 | Registered | S4 | None |
| Clarithromycin 500 MG austell EACH TABLET CONTAINS: CLARITHROMYCIN 500,0 mg | 500 MG | A380476A38/20.1.1/0476 | Registered | S4 | None |
| Mylan clarithromycin 250 MG EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250 mg | A380630A38/20.1.1/0630 | Registered | S4 | None |
| Mylan clarithromycin 500 MG EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 mg | A380631A38/20.1.1/0631 | Registered | S4 | None |
| Claride 250 EACH TABELT CONTAINE CLARITHROMYCIN 250,0 mg | 250 | A380665A38/20.1.1/0665 | Registered | S4 | None |
| Claride 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 | A380666A38/20.1.1/0666 | Registered | S4 | None |
| Klaryvid 250 EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250Film-coated tablets. | A380720A38/20.1.1/0720Approved 16 January 2024 | Registered | S4 | PIPIL |
| Klaryvid 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500Film-coated tablets. | A380721A38/20.1.1/0721Approved 16 January 2024 | Registered | S4 | PIPIL |
| Klarizon 250 EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250 or 500 mgFilm-coated tablets. | A380724A38/20.1.1/0724Approved 21 November 2023 | Registered | S4 | PIPIL |
| Klarizon 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 250 or 500 mgFilm-coated tablets. | A380725A38/20.1.1/0725Approved 21 November 2023 | Registered | S4 | PIPIL |
| Clarihexal125 p EACH 1,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 25,0 mg | Not listed | A390292A39/20.1.1/0292 | Registered | S4 | None |
| Clarihexal 250 p EACH 1,0 ml SUSPENSION CONTAINS CLARITHROMYCIN 50,0 mg | 250 | A390293A39/20.1.1/0293 | Registered | S4 | None |
| Ran-clarithromycin mr 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 mgTablet | A390618A39/20.1.1/0618Approved 27 July 2022 | Registered | S4 | PIPIL |
| Klarithran mr 500 EACH TABLET CONTAINS CLARITHROMYCIN 500,0 mg | 500 mgTablet. | A390619A39/20.1.1/0619Approved 23 August 2023 | Registered | S4 | PIPIL |
| Claren 500 EACH TABLET CONTAINS: CLARITHROMYCIN 500,0 mg | 500 | A400555A40/20.1.1/0555 | Registered | S4 | None |
| Clacee 250 EACH TABLET CONTAINS CLARITHROMYCIN 250,0 mg | 250Tablet | X0229X/20.1.1/229Approved 7 July 2006 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Clarithromycin
S4: Clarithromycin
Consolidated Schedules 06 July 2026, line 5827
Pharmacological class: Broad and medium spectrum antibiotics. (class 20.1.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.